Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04121702
Other study ID # e-CARCEX
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 8, 2019
Est. completion date December 2020

Study information

Verified date October 2019
Source Hospital Universitario 12 de Octubre
Contact Juan Izquierdo Garcia, Therapist
Phone +34917792077
Email juan.izquierdo@salud.madrid.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to establish an innovative Cardiac Tele-Rehabilitation (CTR) model. It could expands assistance resources through coordination with public administrations, developing a physical exercise program (PEP) assistance model in phase II that resolves the current situation of lack of adherence in the PEP due in part to the long waiting time to start it. To sum up this study could improve adherence in Cardiac Rehabilitation Phase III. It represents an opportunity to validate an innovative model for the realization of the PEP for phase II that could be expanded to other centres.


Description:

Cardiac Rehabilitation (CR) programs show benefits in cardiovascular morbidity and mortality, exercise capacity, risk factors and quality of life. The use of new information and communication technologies (ICT) allows remote monitoring of activity and rhythm, defining a new model of cardiac tele-rehabilitation (CTR) and proving to be safe.

The investigators intend to evaluate a new model of CR in Phase II in acute coronary syndrome (ACS), based on the implementation of the physical exercise program (PEP) in a public sports centre (PSC) with tele-monitoring by means of a wearable electronic device, S-PATCH3-Cardio, to compare the adherence of a PEP based on a CTR-PSC model with the traditional in-hospital program (PEP-H) maintaining the efficacy and safety of the CR program.

Patients with recent stratified ACS of low and / or moderate risk will be included who will be randomly assigned to the PEP-H group who will perform 18 PEP sessions with strength training and cardiorespiratory resistance in a hospital, or a CTR-PSC group that performs the 18 sessions of the PEP with strength training and cardiorespiratory resistance in the PSC.

All patients will perform the rest of the CR program at the hospital that it includes: functional tests, consultations with nurse, cardiologist, rehabilitation doctor, and the educational program, with 10 Workshops in a Cardio-healthy Classroom.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 2020
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Recent ACS (1-12 months) of low / moderate risk for the realization of a PEP and without physical impediments for it

- Availability of a mobile phone with Android operating system where you can install the S-PATCH3-Cardio application

- Patients who recognize that they are trained to operate the S-PATCH3-Cardio device after being instructed in its operation and perform a 24-hour simulation.

- Signature of informed consent

Exclusion Criteria:

- Baseline ergospirometry that does not reach maximalist criteria (respiratory quotient> 1.1)

- Mental disability

- Associated comorbidity that prevents performing PEP

Study Design


Intervention

Procedure:
Cardiac Rehabilitation
Implementation of a physical exercise program (PEP) with tele-monitoring

Locations

Country Name City State
Spain Hospital Universitario 12 de Octubre Madrid

Sponsors (1)

Lead Sponsor Collaborator
Juan Izquierdo García

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to physical exercise Adherence to physical exercise measured by number of physical exercise sessions realized by each patient At the end of the program (6 weeks)
Primary Functional capacity Change of functional capacity measured by cardiopulmonary exercise test At the end of the program (6 weeks)
Secondary Glucose levels Evaluate changes on the glucose metabolic profile (mg/dL) At the end of the program (6 weeks)
Secondary Glycated hemoglobin levels (HbA1c) Evaluate changes on the glycated hemoglobin (mg/dL) At the end of the program (6 weeks)
Secondary Low-density lipoprotein (LDL) levels Evaluate changes on the LDL metabolic profile (mg/dL) At the end of the program (6 weeks)
Secondary High-density lipoprotein (HDL) levels Evaluate changes on the HDL metabolic profile (mg/dL) At the end of the program (6 weeks)
Secondary Total colesterol levels Evaluate changes on the total colesterol metabolic profile (mg/dL) At the end of the program (6 weeks)
Secondary Blood pressure levels Evaluate changes on systolic and diastolic blood pressure levels (mmHg) At the end of the program (6 weeks)
Secondary Smoking Evaluate changes on smoking status (cessation of smoking) At the end of the program (6 weeks)
Secondary Weight Evaluate changes on weight (kg) At the end of the program (6 weeks)
Secondary Abdominal perimeter Evaluate changes on abdominal perimeter (cm) At the end of the program (6 weeks)
Secondary Body Mass Index (BMI) Evaluate changes on body mass index (weight in kg and height in meters will be combined to calculate BMI in kg/m^2) At the end of the program (6 weeks)
Secondary Adherence to Mediterranean Diet Evaluate changes on mediterranean dietary habits measured ussing the Mediterranean Diet Assessment Scale (MEDAS) which is constituted by 14 ítems with questions concerning dietary habits related to the medditerranean dietary style. Minimum score: 0, maximum score: 14. Values over 9 are corresponded to good adherence to mediterranean diet, values under 9 are considered to be bad adherence. At the end of the program (6 weeks)
Secondary Phisical exercise profile Evaluate changes on level of physical activity measured ussing the International Physical Activity Questionnaire (IPAQ). It asks about three specific types of activity undertaken in the four domains: leisure time physical activity, domestic and gardening (yard) activities, work-related physical activity, transport-related physical activity. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous-intensity activities. Computation of the total score for the form requires summation of the duration (in minutes) and frequency (days) of walking, moderate-intensity and vigorous-intensity activities.
Maximun value: the sum total of all Walking, Moderate and Vigorous time variables greater than 960 minutes (16 hours).
Mínimum value: Only values of 10 or more minutes of activity should be included in the calculation of summary scores. Responses of less than 10 minutes [and their associated days] should be re-coded to 'zero'
At the end of the program (6 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study